As expected, NPC has a relatively lower mutational burdens with PIK3CA mutations of 1.8% (Table 1), however, there are still numerous of researches involved in PI3K/AKT pathway in NPC. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.